Blog

Each trial may include a custom FAQ section addressing:

• Common eligibility questions
• Time commitment expectations
• Confidentiality and data use policies
• How to withdraw if a participant changes their mind

FAQs are written in plain language and reviewed for ethical accuracy.

Key Note: The Trial Details Page is designed to inform, not persuade. Participation in clinical trials is entirely voluntary, and this page should be used to evaluate whether a particular study aligns with your personal preferences, medical needs, and comfort level.

When available, participants can view:

• Star ratings based on ease of communication, clarity, and overall experience (optional and anonymous)
• Written reviews from previous or current participants

All feedback is moderated for appropriateness and compliance.

The platform recommends similar studies based on:

• Condition of interest
• Geographic location
• Eligibility similarities

This helps participants explore alternatives if a particular study is not a fit.

Participants who want more details or are referred after pre-screening may use this form to:

• Ask follow-up questions
• Clarify trial logistics
• Request a callback or additional documentation

Form submissions are securely transmitted and only shared with authorized site staff.

This section lists:

• Site names (e.g., hospital or research center)
• City and state of each participating location
• Option to filter by proximity

If the trial supports remote participation, that information is also included.

A sidebar or section labeled “Key Information” may display:

• Trial Phase
• Study Duration
• Visit Frequency (e.g., in-person, virtual, hybrid)
• Trial Sponsor
• IRB Approval Status
• Estimated Compensation (if applicable)

All compensation details are presented in a neutral, non-incentivizing manner.

The trial’s inclusion and exclusion criteria are listed to help users understand basic eligibility requirements. Examples include:

• Age and gender requirements
• Diagnosed conditions
• Exclusion factors (e.g., current use of certain medications)

Key Note: These criteria are informational. Final eligibility is determined after detailed screening by the research team. Meeting the basic eligibility criteria listed here does not guarantee enrollment; the final decision rests with the trial site or sponsor after their review.

This section includes:

• A brief summary of the trial’s purpose in plain language.
• A longer, structured description that outlines:
  • The condition being studied
  • Type of intervention or procedure
  • Study goals or endpoints
  • Participation expectations

The language is kept participant-friendly and free of coercive or overly technical terms, in line with ethical standards.

Each trial is tagged with key attributes to aid in quick comprehension and filtering:

• Phase of the Trial (e.g., Phase 1, Phase 2)
• Age Group (e.g., Adults 18+, Seniors 65+)
• Gender (e.g., Open to all genders, or gender-specific studies)
• Volunteer Type (e.g., Healthy Volunteers, Condition-Specific Participants)
• Recruitment Status (e.g., Actively Enrolling, Temporarily Paused)

These tags also serve as clickable filters to discover similar studies.

At the top of the page, users will see:

• Trial Title: The official title of the study as provided by the sponsor or research site.
• Action Buttons:
  • Start Pre-Screener: Begin the screening process to assess eligibility.
  • Share Trial: Copy or send a secure trial link to someone else (optional).